It has been reported that exosomal PD-L1 significantly decreased T cell surface CD69 and PD-1 expressions, suggesting that the levels of exosomal PD-L1 reflect the immune status in patients with GC [71]. This evidence concerns the gene CD274 and gastric cancer.